Comparison of EORTC subscales compared to established norms
| . | EORTC QLQ-C30 Scores (mean ± SD) . | ||||||
|---|---|---|---|---|---|---|---|
| Current data . | Samuelsson 200610 . | EORTC 200811 . | |||||
| ET (n = 161) . | PV (n = 145) . | MF (n = 96) . | PV and ET (N = 37-38) . | General population (N = 7802) . | Recurrent/metastatic cancer (N = 4812) . | AML (N = 155) . | |
| EORTC subscales | |||||||
| Physical functioning | 85.1 ± 16.9 | 83.3 ± 17.7 | 74.9 ± 20.7 | 90.6 ± 11.5 | 89.8 ± 16.2 | 75.8 ± 23.1 | N/A |
| Role functioning | 85.0 ± 23.0 | 85.2 ± 22.7 | 68.8 ± 28.9 | 81.5 ± 24.5 | 84.7 ± 25.4 | 60.7 ± 35.1 | N/A |
| Emotional functioning | 77.7 ± 22.9 | 78.2 ± 20.8 | 76.5 ± 20.5 | 82.4 ± 17.1 | 76.3 ± 22.8 | 68.7 ± 24.8 | 82.2 ± 18.9 |
| Cognitive functioning | 83.4 ± 19.4 | 83.0 ± 18.8 | 77.0 ± 20.4 | 86.7 ± 17.4 | 86.1 ± 20.0 | 80.5 ± 23.2 | 86.1 ± 18.5 |
| Social functioning | 88.4 ± 19.7 | 88.3 ± 20.1 | 74.9 ± 24.1 | 89.6 ± 18.6 | 87.5 ± 22.9 | 70.5 ± 30.7 | 66.1 ± 31.0 |
| Global health status/QOL | 71.1 ± 24.9 | 65.7 ± 24.8 | 59.9 ± 24.6 | 72.1 ± 23.4 | 71.2 ± 22.4 | 56.3 ± 25.6 | N/A |
| EORTC symptom scales | |||||||
| Fatigue | 26.9 ± 25.5 | 29.3 ± 21.9 | 41.0 ± 25.1 | 23.1 ± 24.1 | 24.1 ± 24.0 | 41.8 ± 29.4 | 36.2 ± 22.7 |
| Nausea/vomiting | 4.0 ± 9.7 | 3.3 ± 8.2 | 6.3 ± 11.4 | 2.6 ± 6.2 | 3.7 ± 11.7 | 13.1 ± 22.5 | 9.0 ± 18.3 |
| Pain | 14.3 ± 23.1 | 14.6 ± 20.4 | 22.6 ± 27.8 | 15.4 ± 25.2 | 20.9 ± 27.6 | 33.7 ± 32.4 | 13.7 ± 20.4 |
| Dyspnea | 18.5 ± 25.8 | 19.6 ± 24.2 | 29.8 ± 29.0 | 10.6 ± 15.7 | 11.8 ± 22.8 | 23.4 ± 30.1 | 11.3 ± 17.1 |
| Insomnia | 25.0 ± 27.4 | 26.6 ± 28.0 | 33.7 ± 30.6 | 19.3 ± 27.5 | 21.8 ± 29.7 | 33.6 ± 33.4 | 20.4 ± 26.1 |
| Appetite loss | 5.1 ± 14.7 | 10.3 ± 21.7 | 15.1 ± 23.1 | 2.6 ± 9.1 | 6.7 ± 18.3 | 28.2 ± 34.9 | 18.0 ± 30.5 |
| Constipation | 19.0 ± 29.0 | 13.4 ± 24.5 | 16.8 ± 26.1 | 4.4 ± 13.8 | 6.7 ± 18.4 | 23.2 ± 32.3 | 7.9 ± 19.1 |
| Diarrhea | 9.0 ± 18.3 | 6.3 ± 16.3 | 21.1 ± 27.1 | 4.4 ± 11.4 | 7.0 ± 18.0 | 10.7 ± 22.4 | 12.6 ± 25.1 |
| Financial difficulties | 8.0 ± 19.3 | 6.4 ± 15.9 | 17.5 ± 28.7 | 7.2 ± 17.8 | 9.5 ± 23.3 | 16.2 ± 27.7 | 18.7 ± 28.8 |
| . | EORTC QLQ-C30 Scores (mean ± SD) . | ||||||
|---|---|---|---|---|---|---|---|
| Current data . | Samuelsson 200610 . | EORTC 200811 . | |||||
| ET (n = 161) . | PV (n = 145) . | MF (n = 96) . | PV and ET (N = 37-38) . | General population (N = 7802) . | Recurrent/metastatic cancer (N = 4812) . | AML (N = 155) . | |
| EORTC subscales | |||||||
| Physical functioning | 85.1 ± 16.9 | 83.3 ± 17.7 | 74.9 ± 20.7 | 90.6 ± 11.5 | 89.8 ± 16.2 | 75.8 ± 23.1 | N/A |
| Role functioning | 85.0 ± 23.0 | 85.2 ± 22.7 | 68.8 ± 28.9 | 81.5 ± 24.5 | 84.7 ± 25.4 | 60.7 ± 35.1 | N/A |
| Emotional functioning | 77.7 ± 22.9 | 78.2 ± 20.8 | 76.5 ± 20.5 | 82.4 ± 17.1 | 76.3 ± 22.8 | 68.7 ± 24.8 | 82.2 ± 18.9 |
| Cognitive functioning | 83.4 ± 19.4 | 83.0 ± 18.8 | 77.0 ± 20.4 | 86.7 ± 17.4 | 86.1 ± 20.0 | 80.5 ± 23.2 | 86.1 ± 18.5 |
| Social functioning | 88.4 ± 19.7 | 88.3 ± 20.1 | 74.9 ± 24.1 | 89.6 ± 18.6 | 87.5 ± 22.9 | 70.5 ± 30.7 | 66.1 ± 31.0 |
| Global health status/QOL | 71.1 ± 24.9 | 65.7 ± 24.8 | 59.9 ± 24.6 | 72.1 ± 23.4 | 71.2 ± 22.4 | 56.3 ± 25.6 | N/A |
| EORTC symptom scales | |||||||
| Fatigue | 26.9 ± 25.5 | 29.3 ± 21.9 | 41.0 ± 25.1 | 23.1 ± 24.1 | 24.1 ± 24.0 | 41.8 ± 29.4 | 36.2 ± 22.7 |
| Nausea/vomiting | 4.0 ± 9.7 | 3.3 ± 8.2 | 6.3 ± 11.4 | 2.6 ± 6.2 | 3.7 ± 11.7 | 13.1 ± 22.5 | 9.0 ± 18.3 |
| Pain | 14.3 ± 23.1 | 14.6 ± 20.4 | 22.6 ± 27.8 | 15.4 ± 25.2 | 20.9 ± 27.6 | 33.7 ± 32.4 | 13.7 ± 20.4 |
| Dyspnea | 18.5 ± 25.8 | 19.6 ± 24.2 | 29.8 ± 29.0 | 10.6 ± 15.7 | 11.8 ± 22.8 | 23.4 ± 30.1 | 11.3 ± 17.1 |
| Insomnia | 25.0 ± 27.4 | 26.6 ± 28.0 | 33.7 ± 30.6 | 19.3 ± 27.5 | 21.8 ± 29.7 | 33.6 ± 33.4 | 20.4 ± 26.1 |
| Appetite loss | 5.1 ± 14.7 | 10.3 ± 21.7 | 15.1 ± 23.1 | 2.6 ± 9.1 | 6.7 ± 18.3 | 28.2 ± 34.9 | 18.0 ± 30.5 |
| Constipation | 19.0 ± 29.0 | 13.4 ± 24.5 | 16.8 ± 26.1 | 4.4 ± 13.8 | 6.7 ± 18.4 | 23.2 ± 32.3 | 7.9 ± 19.1 |
| Diarrhea | 9.0 ± 18.3 | 6.3 ± 16.3 | 21.1 ± 27.1 | 4.4 ± 11.4 | 7.0 ± 18.0 | 10.7 ± 22.4 | 12.6 ± 25.1 |
| Financial difficulties | 8.0 ± 19.3 | 6.4 ± 15.9 | 17.5 ± 28.7 | 7.2 ± 17.8 | 9.5 ± 23.3 | 16.2 ± 27.7 | 18.7 ± 28.8 |
N/A indicates not available; and QOL, quality of life.